Elizabeth Davis
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression (NCT03724968) | Elizabeth Davis | 2019-01-17 |
Track Elizabeth Davis automatically
Every clearance here is in the API, with alerts when new ones post.